Favourable response to splenectomy in familial myelodysplastic syndrome

J Abdul-Wahab1, M Naznin, A Suhaimi

  • 1Department of Paediatrics, Faculty of Medicine, International Islamic University of Malaysia, PO Box 141, Kuantan 27510, Malaysia. nasyrah_wahab@yahoo.com

Insights

Familial myelodysplastic syndrome (MDS) is a rare childhood cancer. In a unique case, two siblings with MDS showed stable disease, with one experiencing complete recovery after splenectomy.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Genetics

Background:

  • Familial myelodysplastic syndrome (MDS) is an exceptionally rare hematological malignancy in children.
  • Early-onset MDS often suggests an underlying genetic predisposition.

Observation:

  • Two siblings from a consanguineous marriage presented with pancytopenia.
  • The siblings, aged three and 18 years, were diagnosed with myelodysplastic syndrome.
  • Both patients maintained clinical stability during their illness.

Findings:

  • Myelodysplastic syndrome in young siblings is a rare occurrence.
  • Splenectomy was performed on one sibling.
  • The splenectomy procedure appeared to fully resolve the cytopenia in the treated sibling.

Implications:

  • This case highlights the potential genetic basis of familial MDS in pediatric patients.
  • Splenectomy may be a viable therapeutic option for cytopenia correction in select cases of familial MDS.
  • Further research into the genetic factors and treatment modalities for childhood MDS is warranted.